Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis)

European Journal of Dermatology

Volumn 16, Issue 1, 2006, Pages 17-22

  El Darouti, Mohammad A ^a   Marzouk, Salonaz A ^a   Azzam, Omar ^a   Fawzi, Marwa Mohsen ^a   Abdel Halim, Mona R E ^a   Zayed, Amira A ^a   Leheta, Tahra M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Epidermotropism; Histopathology; Hypopigmented MF; Immunohistochemistry; Melanocytes; Vitiligo

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; EOSIN; HEMATOXYLIN;

ADULT; ARTICLE; BASAL CELL; BASEMENT MEMBRANE; CD8+ T LYMPHOCYTE; CELL DEGENERATION; CELL DENSITY; CELL DIFFERENTIATION; CELL INFILTRATION; COST BENEFIT ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOPIGMENTATION; IMMUNOHISTOCHEMISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MYCOSIS FUNGOIDES; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS; VITILIGO; WORINGER KOLOPP DISEASE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPIGMENTATION; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS; VITILIGO;

EID: 32344446972     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. El Shabrawi-Caelen L, Cerroni L, Mederios LJ, McCalmont TH. Hypopigmented mycosis fungoides. Frequent expression of a CD8+ T-cell phenotype. Am J Surg Pathol 2002; 26: 450.
2. Ardig M, Borroni G, Muscardin L, Kerl H, Cerroni L. Hypopigmented MF in Caucasian patients: A clinicopathologic study of 7 cases. J Am Acad Dermatol 2003; 49(2): 264.
3. Neuhaus IM, Ramos-Caro FA, Hassanein AM. Hypopigmented mycosis fungoides in childhood and adolescence Pediatr Dermatol 2000; 17: 403.
4. Robert C, Moulonguet I, Baudot N, Flageul B, Dubertret L. Hypopigmented mycosis fungoides in a light-skinned women. Br J Dermatol 1998; 139: 341.
5. Cribier B, Snatinelli F, Lipsker D, Gosshans E. Vitiligo with inflammatory raised border mimicking mycosis fungoides. A clinicopathological study of 4 cases. Am J Dermatopathol 2000; 4: 349.
6. Petit T, Cribier B, Bagot M, Wechsler J. Inflammatory vitiligo-like macules that stimulate hypopigmented mycosis fungoides. Eur J Dermatol 2002; 13(4): 410.
7. Volkenandt M, Soyer HP, Cerronl L, Koch OM, Atzpodin J, Kerl H. Molecular detection of clone-specific DNA in hypopigmented lesions of a patient with early evolving mycosis fungoides. Br J Dermatol 1993; 128: 423.
8. Weiss L, Wood GS, Trela M, Warnke RA, Sklar J. T cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med 1986; 315(8): 475.
9. Vega F, Luthra R, Medeiros LJ, Dunmire V, Lee SJ, Duvic M, et al. Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood 2002; 100: 3369.
10. Werner B, Brown S, Ackerman AB. Hypopigmented mycosis fungoides is not always mycosis fungoides. Am J Dermatopathol 2005; 27: 56.
11. Dawson B, Trap RG. Basic and clinical biostatistics. 3rd edition Lange medical books. McGraw Hill, 2001.
12. Bhawan J, Bhutani LK, Kerahnocyte damage in vitiligo. J Cut Pathol 1983; 10: 207.
13. Breathnach AS, Bor S, Wyllie LMA. Electron microscopy of peripheral nerve terminals and marginal melanocytes in vitiligo. J Inves. Dermatol 1966; 47: 125.
14. Hann S, Park YK, Lee KG. Epidermal changes in active vitiligo. J Dermatol 1992; 19: 217.
15. Le Poole IC, van den Wijngaard RMJGJ, Westerhof W, Dutrieux R, Das PK Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 1993; 100: 816.
16. Horn TD. Analysis of the lymphocytic infiltrate in a case of vitiligo. Am J Dermatopathol 1997; 19: 400.
17. Akaraphanth R, Douglass MC, Lim HW. Hypopigmented mycosis fungoides treatment and a 6-year follow-up of 9 patients. J Am Acad Dermatol 2000; 42: 33.
18. Zackheim HS, Epstein Jr. EH, Grekin DA, McNutt NS. Mycosis fungoides presenting as areas of hypopigmentation. J Am Acad Dermatol 1982; 6: 340.
19. Breathnach SM, McKee PH, Smith NP. Hypopigmented mycosis fungoides: report of five cases with ultrastructural observations. Br J Dermatol 1982; 106: 643.
20. Goldberg DI, Schinella RS, Kechijian P. Hypopigmented mycosis fungoides. Am J Dermatopathol 1986: 326.
21. Fogelman JP, Bolognia J, Heald P, McNiff JM. Destruction of a congenital nevus by halo-like phenomenon secondary to cutaneous T-cell lymphoma. J Cutan Pathol 1997; 24: 97.
22. Mimouni D, David M, Feinmesser M, Coire CI, Hodak E. Vitiligo-like leukoderma during photochemotherapy for mycosis fungoides. Br J Dermatol 2001; 145: 1008.
23. Boulac A, Grange F, Delfau-Larue MH, Dieng MT, Tortel MC, Avril MF, et al. Leucoderma associated with flares of erythrodermia cutaneous T cell lymphomas four cases. Br J Dermatol 2000; 143 832.
24. Castanet J, Ortonne J. Pathophysiology of vitiligo. Clin Dermatol 1997; 15: 845.
25. Palmero B, Campanelli R, Garblli S, Mantovani S, Lantelme E, Brazzelli V, et al. Specific cytotoxic T lymphocyte responses against Melan-AMART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramersthe role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 2000; 117: 326.
26. Lang KS, Caroli CC, Muhm A, Wernet D, Moris A, Schittek B, et al. HLA-A2 restricted, melanocyte-specfic CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J Invest Dermatol 2001; 116: 891.
27. Goudie RB. Two views of the origin of vitiligo. Lancet 1991; 338: 316.
28. Wain EM, Orchard GE, Whittaker SJ, Spittle MSCMF, Russell Jones R. Outcome in 34 patients with juvenile-onset mycosis fungoides clinical, immunopnenotypic and molecular study. Cancer 2003; 98(10): 2282.
29. Di L-A, Marchesi L, Naldi L, Motta M, Cainelli T. A case of hypopigmented mycosis fungoides in a young Caucasian boy Pediatr Dermatol 1997; 14(6): 449.